ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

HCM Hutchmed (china) Limited

310.00
0.00 (0.00%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Hutchmed (china) Limited HCM 런던 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 310.00 00:35:23
개장가 저가 고가 종가 전일 종가
311.00 303.00 314.00 310.00 310.00
시세 정보 더보기 »
산업 분야
PHARMACEUTICALS & BIOTECHNOLOGY

최근 뉴스

일자 시간 출처 제목
27/04/202400:09ALNCNewsHutchmed notes CHMP's positive opinion for fruiquintinib..
26/04/202421:30UK RNSHutchmed (China) Limited Positive CHMP Opinion for..
22/04/202417:30UK RNSHutchmed (China) Limited Vesting of Awards Under the LTIP
08/04/202417:30UK RNSHutchmed (China) Limited 2023 Annual Report and Notice of..
05/04/202417:30UK RNSHutchmed (China) Limited Data to be Presented at AACR..
02/04/202418:32ALNCNewsHutchmed endometrial cancer treatment application accepted..
02/04/202415:00UK RNSHutchmed (China) Limited HUTCHMED and Innovent Announce NDA..
28/03/202420:08ALNCNewsHutchmed lung cancer treatment accepted for review in China
28/03/202416:00UK RNSHutchmed (China) Limited Savolitinib sNDA Accepted in China
22/03/202419:09ALNCNewsHutchmed begins registration stage for sovleplenib phase 2/3..
22/03/202416:16ALNCNews*CORRECT: Hutchmed China initiates registration for phase 3..
22/03/202416:00UK RNSHutchmed (China) Limited Initiation of Registration Stage of..
14/03/202418:00UK RNSHutchmed (China) Limited LTIP and Share Option Scheme
05/03/202417:30UK RNSHutchmed (China) Limited Vesting of awards under the LTIP
29/02/202402:31ALNCNewsEARNINGS: Hutchmed revenue surges, Craven House's loss..
28/02/202421:45UK RNSHutchmed (China) Limited Publication of Form 20-F
28/02/202420:30UK RNSHutchmed (China) Limited 2023 Full Year Results and Business..
07/02/202418:50ALNCNewsHutchmed hails fruquintinib trial results for gastric cancer..
07/02/202416:00UK RNSHutchmed (China) Limited Presentation of Phase III Data on..
02/02/202418:52ALNCNewsHutchmed says Inmagene exercises option to licence drug..
02/02/202417:37UK RNSHutchmed (China) Limited Inmagene Exercises Option for Two..
01/02/202417:30UK RNSHutchmed (China) Limited HUTCHMED to Announce 2023 Final..
30/01/202418:20ALNCNewsHutchmed celebrates cancer drug approval in hometown of Hong..
30/01/202416:12UK RNSHutchmed (China) Limited HUTCHMED Receives Marketing..
11/01/202419:17ALNCNewsTOP NEWS: Hutchmed Sovleplenib accepted for review by China..
11/01/202416:00RNSNONHutchmed (China) Limited Sovleplenib NDA Granted Priority..
29/12/202317:30UKREGHutchmed (China) Limited Total Voting Rights
29/12/202317:30UKREGHutchmed (China) Limited Blocklisting Six Monthly Return
21/12/202320:36ALNCNewsIN BRIEF: Hutchmed China renews deals with "substantial"..
21/12/202319:00UKREGHutchmed (China) Limited Overseas Regulatory Announcement
13/12/202322:56ALNCNewsHutchmed completes enrolment for fruquintinib trial
13/12/202316:00RNSNONHutchmed (China) Limited Completed Enrollment of Phase..
07/12/202319:04UKREGHutchmed (China) Limited Overseas Regulatory Announcement
01/12/202316:00RNSNONHutchmed (China) Limited Clinical Data to be Presented at..
30/11/202317:30UKREGHutchmed (China) Limited Total Voting Rights
09/11/202321:16ALNCNewsHutchmed hails Takeda's fruquintinib approval from US for..
09/11/202316:00UKREGHutchmed (China) Limited U.S. FDA Approval of FRUZAQLA(TM)..
24/10/202317:30UKREGHutchmed (China) Limited Vesting of awards under the LTIP
16/10/202317:30RNSNONHutchmed (China) Limited Clinical Data to be Presented at..
29/09/202318:12ALNCNewsHutchmed notes Takeda submits fruquintinib drug application..
29/09/202317:30UKREGHutchmed (China) Limited Total Voting Rights
29/09/202317:30RNSNONHutchmed (China) Limited NDA Submission for Fruquintinib in..
14/09/202317:30UKREGHutchmed (China) Limited Director's Share Dealing
12/09/202318:26ALNCNewsIN BRIEF: Hutchmed China finalises patient enrolment for..
12/09/202317:30RNSNONHutchmed (China) Limited Phase IIIb Savolitinib Results at..
12/09/202315:00RNSNONHutchmed (China) Limited Patient Enrollment Completed for..
31/08/202317:30UKREGHutchmed (China) Limited Total Voting Rights
29/08/202317:30ALNCNewsIN BRIEF: China grants Hutchmed's savolitinib breakthrough..
29/08/202315:00RNSNONHutchmed (China) Limited BTD in China for Savolitinib for..
21/08/202316:46ALNCNewsHutchmed China hails trial on sovleplenib meeting primary..

최근 히스토리

Delayed Upgrade Clock